243
Views
16
CrossRef citations to date
0
Altmetric
Research Article

The autoimmune nature of post-infarct myocardial healing: oral tolerance to cardiac antigens as a novel strategy to improve cardiac healing

, , , , , & show all
Pages 233-244 | Received 30 Jan 2011, Accepted 01 Dec 2011, Published online: 07 Feb 2012

References

  • Harty M, Neff AW, King MW, Mescher AL. Regeneration or scarring: an immunologic perspective. Dev Dyn. 2003; 226:268–279.
  • Bujak M, Frangogiannis NG. The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Card Res. 2007; 74:184–195.
  • Stramer BM, Mori R, Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol. 2007; 127:1009–1017.
  • Liao Y, Cheng X. Autoimmunity in myocardial infarction. Int J Cardiol. 2006; 112:21–26.
  • McCallion RL, Ferguson MWJ. 1995. Fetal wound healing and the development of anti-scarring therapies for adult wound healing. In: Clark RAF. editors. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press561–600.
  • Whitby DJ, Ferguson MWJ. Immunolocalization of growth factors in fetal wound healing. Dev Biol. 1991; 47:2207–2215.
  • Lessof M. Immunological reactions in heart disease. Brit Heart J. 1978; 40:211–214.
  • De Scheerder I, Vandekerckhove J, Robbrecht J, Algoed L, De Buyzere M, De Langhe J, De Schrijver G, Clement D. Post-cardiac syndrome and an increased humoral immune response against the major contractile proteins (actin and myosin). Am J Cardiol. 1985; 56:631–633.
  • De Scheerder IK, De Buyzere ML, De Langhe JR, Clement DL, Wieme RJ. Anti-myosin humoral immune response following cardiac injury. Autoimmunity. 1989; 4:51–58.
  • Maisel A, Cesario D, Baird S, Rehman J, Haghighi P, Carter S. Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction. Circ Res. 1998; 82:458–463.
  • Varda-Bloom N, Leor J, Ohad DG, Hasin Y, Amar M, Fixler R, Battler A, Eldar M, Hasin D. Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J Mol Cell Cardiol. 2000; 32:2141–2149.
  • Curato C, Slavic S, Dong J, Skorska A, Altarche-Xifró W, Miteva K, Kaschina E, Thiel A, Imboden H, Wang J, Steckelings U, Steinhoff G, Unger T, Li J. Identification of noncytotoxic and IL-10-producing CD8+AT2R+T cell population in response to ischemic heart injury. J Immunol. 2010; 185 10: 6286–6293.
  • Dobaczewski M, Xia Y, Bujak M, Gonzalez-Quesada C, Frangogiannis NG. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol. 2010; 176 5: 2177–2187.
  • Kloner RA, Fishbein MC, Lew H, Maroko PR, Braunwald E. Mummification of the infracted myocardium by high dose corticosteroids. Circulation. 1978; 57:56–64.
  • Yu Q, Watson RR, Marchalonis JJ, Larson DF. A role for T lymphocytes in mediating cardiac diastolic function. Am J Physiol Heart Circ Physiol. 2005; 289:H643–H655.
  • Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res. 2009; 104 2: e9–18.
  • Vaz NM, Maia LC, Hanson DG, Lynch JM. Inhibition of homocytotropic antibody responses in adult inbred mice by previous feeding of the specific antigen. J Allergy Clin Immunol. 1977; 60:110–115.
  • Verdolin BA, Ficker SM, Faria AMC, Vaz NM, Carvalho CR. Stabilization of serum antibody responses triggered by initial mucosal contact with the antigen independently of oral tolerance induction. Braz J Med Biol Res. 2001; 34:211–219.
  • Costa RA, Ruiz-de-Souza V, Azevedo GMJr, Gava E, Kitten GT, Vaz NM, Carvalho CR. Indirect effects of oral tolerance improve wound healing in skin. Wound Repair Regen. 2011; 19 4: 484–497.
  • Faria AMC, Weiner HL. Oral tolerance. Immunol Rev. 2005; 206:232–259.
  • Rona G, Chappel CL, Balazs T, Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in rat. AMA Arch Pathol. 1959; 67:443–455.
  • Teerlink JR, Pfeffer JM. Progressive ventricular remodeling in responses to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res. 1994; 75:105–114.
  • Todd CW, Todd NR, Guimaraes AC. Do lymphocytes from chagasic patients respond to heart antigens?. Infect Immun. 1983; 40:832–835.
  • da Cunha AP, Vaz NM, Carvalho CR. Study of oral tolerance and its indirect effects in adoptive cell transfer experiments. Ann NY Acad Sci. 2004; 1029:321–327.
  • Ramos GC, Rodrigues CM, Azevedo GM, Pinho V, Carvalho CR, Vaz NM. Cell-mediated immune responses to unrelated proteins and unspecific inflammation blocked by orally tolerated proteins. Immunology. 2009; 126:354–362.
  • Castro CH, Santos RA, Ferreira M, Bader M, Alenina N, Almeida AP. Effects of genetic deletion of angiotensin-(1-7) receptor Mas on cardiac function during ischemia/reperfusion in the isolated perfused mouse heart. Life Sci. 2006; 80:264–268.
  • Morales C, González GE, Rodríguez M, Bertolasi CA, Gelpi RJ. Histopathologic time course of myocardial infarct in rabbit hearts. Cardiovasc Pathol. 2002; 11:339–345.
  • Pick R, Jalil JE, Janicki JS, Weber KT. The fibrilar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. Am J Pathol. 2008; 134:365–371.
  • Campos EC, Romano MM, Prado CM, Rossi MA. Isoproterenol induces primary loss of dystrophin in rat hearts: correlation with myocardial injury. Int J Exp Pathol. 2008; 89:367–381.
  • Rona G, Kahn DS, Chappel CL. Studies on infarct-like myocardial necrosis produced by isoproterenol: a review. Rev Can Biol. 1963; 22:241–255.
  • Ferrans VJ, Hibbs RG, Black WC, Weilbaecher DG. Isoproterenol-induced myocardial necrosis. A histochemical and electron microscopy study. Am Heart J. 1964; 68:71–90.
  • Matzinger P, Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol. 2011; 11:221–230.
  • Parissis JT, Adamopoulos S, Venetsanou KF, Mentzikof DG, Karas SM, Kremastinos DT. Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in post-infarction left ventricular remodeling. J Interferon Cytokine Res. 2002; 22 2: 223–229.
  • Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Therap. 2009; 123:255–278.
  • Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem. 2001; 276:37672–37679.
  • Hori S, Nomura T, Sakagushi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299:1057–1061.
  • Lafaille C, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?. Immunity. 2009; 30:626–635.
  • Kushner I, Kaplan MH. Antigenic analysis of extracts of human heart tissue: cardiac antigens with limited distribution in other organs. J Immunol. 1967; 99:526–533.
  • Espinosa E, Kaplan MH. Antigenic analysis of human heart tissue. J Immunol. 1971; 108:611–618.
  • Keller AC, Mucida D, Gomes E, Faquim-Mauro E, Faria AM, Rodriquez D, Russo M. Hierarchical supression of asthma-like responses by mucosal tolerance. J Allergy Clin Immunol. 2006; 117:282–290.
  • Gonnella PA, Nido PJ, McGowan FX. Oral tolerization with cardiac myosin peptide (614–629) ameliorates experimental autoimmune myocarditis: role of STAT 6 genes in BALB/CJ mice. J Clin Immunol. 2009; 29:434–443.
  • Frenkel Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury. Int Immunol. 2009; 21:817–829.
  • Coutinho A, Kazatchkine MD, Avrameas SNatural autoantibodies.. 1995; 7:812–818.
  • Pereira P, Forni L, Larsson EL, Cooper M, Heusser C, Coutinho A. Autonomous activation of B and T cells in antigen-free mice. Eur J Immunol. 1986; 16 6: 685–688.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.